Abiopharma

(50% Neutral) OPTINOSE, INC. (OPTN) Files Form 8-K

(10% Negative) PTC THERAPEUTICS, INC. (PTCT) Files Form 8-K

(70% Positive) Olema Pharmaceuticals, Inc. (OLMA) Announces Business Combination

(10% Negative) Eagle Pharmaceuticals, Inc. (EGRX) Files Form 8-K

(10% Negative) Blueprint Medicines Corporation (BPMC) Announces Delay in contained Trials for promotional use Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

(99% Neutral) Castle Biosciences, Inc. (CSTL) Announces Regulatory Update

(99% Neutral) Oyster Point Pharma, Inc. (OYST) Files Form 8-K

(10% Negative) Aquestive Therapeutics, Inc. (AQST) Announces Delay in advisor Trials for a registered direct offering Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Positive) CureVac (CVAC) Announces Clinical Development Update (Form 6-K)